Education
About Us
Working with TipRanks
Follow Us
Medrx Co., Ltd. (JP:4586)
:4586
Total Valuation
Medrx Co., Ltd. has a market cap or net worth of ¥3.48B. The enterprise value is ¥1.54B.
Market Cap¥3.48B
Enterprise Value¥1.54B
Share Statistics
Medrx Co., Ltd. has 53,495,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,495,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medrx Co., Ltd.’s return on equity (ROE) is -0.37 and return on invested capital (ROIC) is -36.73%.
Return on Equity (ROE)-0.37
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-36.73%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee11.68M
Profits Per Employee-36.64M
Employee Count22
Asset Turnover0.11
Inventory Turnover3.77
Valuation Ratios
The current PE Ratio of Medrx Co., Ltd. is -4.42. Medrx Co., Ltd.’s PEG ratio is 0.08.
PE Ratio-4.42
PS Ratio0.00
PB Ratio1.65
Price to Fair Value1.64
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.08
Income Statement
In the last 12 months, Medrx Co., Ltd. had revenue of 257.00M and earned -806.00M in profits. Earnings per share was -18.54.
Revenue257.00M
Gross Profit219.19M
Operating Income-793.00M
Pretax Income-802.00M
Net Income-806.00M
EBITDA-764.31M
Earnings Per Share (EPS)-18.54
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Medrx Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.50
52-Week Price Change-60.92%
50-Day Moving Average62.80
200-Day Moving Average81.13
Relative Strength Index (RSI)56.18
Average Volume (3m)391.46K
Important Dates
Medrx Co., Ltd. upcoming earnings date is Aug 8, 2025, TBA (Confirmed).
Last Earnings DateMay 9, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend Date―
Financial Position
Medrx Co., Ltd. as a current ratio of 19.73, with Debt / Equity ratio of 0.00%
Current Ratio19.73
Quick Ratio19.64
Debt to Market Cap0.00
Net Debt to EBITDA2.59
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medrx Co., Ltd. has paid 4.00M in taxes.
Income Tax4.00M
Effective Tax Rate>-0.01
Enterprise Valuation
Medrx Co., Ltd. EV to EBITDA ratio is -2.08, with an EV/FCF ratio of -1.98.
EV to Sales6.18
EV to EBITDA-2.08
EV to Free Cash Flow-1.98
EV to Operating Cash Flow-1.98
Balance Sheet
Medrx Co., Ltd. has ¥1.98B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -¥1.98B billion.
Cash & Marketable Securities¥1.98B
Total Debt¥0.00
Net Cash-¥1.98B
Net Cash Per Share-¥36.96
Tangible Book Value Per Share¥49.88
Margins
Gross margin is 88.32%, with operating margin of -308.56%, and net profit margin of -313.62%.
Gross Margin88.32%
Operating Margin-308.56%
Pretax Margin-312.06%
Net Profit Margin-313.62%
EBITDA Margin-297.40%
EBIT Margin-312.35%
Analyst Forecast
The average price target for Medrx Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast773.28%
EPS Growth Forecast35.71%